Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEFITINIB vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEFITINIB vs GEMFIBROZIL: Safety Overview

Metric GEFITINIB GEMFIBROZIL
Total FAERS Reports 4,697 1,089
Deaths Reported 1,047 101
Death Rate 22.3% 9.3%
Hospitalizations 853 286
Average Patient Age 66.4 yrs 56.7 yrs
% Female Patients 66.4% 49.9%
FDA Approval Date Apr 26, 2023 Approved Prior to Jan 1, 1982
Manufacturer Teva Pharmaceuticals, Inc. Northwind Health Company, LLC
Route ORAL ORAL
Marketing Status Discontinued Discontinued